Given they have already advised revenue in excess of $19M and the inventory is going to be capitalised, I put the FY loss at $18M - $20M (6.0c - 6.7c per share).
The muting of capital raising is interesting because they still had $18M of cash at 30 June. Why now?
Good news has to be close with the DTT trial although I noted implants dropped off in August.
Cap raising through shares is suicide at the current SP, so what is going on?
VCR
ventracor limited
announcement
-
- There are more pages in this discussion • 11 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)